Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cara Therapeutics
(NQ:
CARA
)
0.2970
-0.0134 (-4.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cara Therapeutics
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 24, 2021
Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
August 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...
Via
Benzinga
Exposures
Product Safety
See Why Cara Therapeutics (CARA) Stock Is Moving Higher On Tuesday
August 24, 2021
The FDA has approved Cara Therapeutics Inc (NASDAQ: CARA) and Vifor Pharma AG’s Korsuva (difelikefalin) injection for severe-to-moderate pruritis (...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
20 Stocks Moving in Tuesday's Pre-Market Session
August 24, 2021
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) rose 48.3% to $0.777 in pre-market trading after gaining over 3% on Monday. The company, earlier during the month, reported downbeat...
Via
Benzinga
Vifor Pharma and Cara Therapeutics announce U.S. FDA approval of KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients
August 24, 2021
From
Vifor Pharma Group
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
August 23, 2021
Gainers Cara Therapeutics (NASDAQ:CARA) ...
Via
Benzinga
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
August 22, 2021
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues,...
Via
Benzinga
Exposures
Product Safety
Top Marijuana Stocks, Movers For August 10, 2021
August 10, 2021
GAINERS: Body and Mind
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cara Therapeutics, inc (CARA) Q2 2021 Earnings Call Transcript
August 09, 2021
CARA earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Cara Therapeutics: Q2 Earnings Insights
August 09, 2021
Shares of Cara Therapeutics (NASDAQ:CARA) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 12.96% year over...
Via
Benzinga
Body & Mind & Charlottes Web Among Top Cannabis Stock Movers On August 6, 2021
August 06, 2021
GAINERS: Body and Mind
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Is Cannabis The Hottest Market Right Now? Aurora, Canopy And Sundial Among Top Bullish Stocks For August 5, 2021
August 05, 2021
GAINERS: 22nd Century Group (AMEX:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Stocks That Hit 52-Week Lows On Wednesday
August 04, 2021
Wednesday's morning session saw 58 companies set new 52-week lows. Noteworthy Mentions: The company with the largest market cap to set a new 52-week low was...
Via
Benzinga
Mixed Feelings About Cannabis Stocks, Check Out How The Top Movers Did On August 3, 2021
August 03, 2021
GAINERS: Cipher Pharms Inc (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2021
August 03, 2021
Upgrades For SolarEdge Technologies Inc (NASDAQ:
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
August 02, 2021
The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi...
Via
Benzinga
AusCann, Flower One, Item 9 Labs & MariMed Among Top Cannabis Stock Movers On July 23, 2021
July 23, 2021
GAINERS: Cann Gr (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Sentiment Pumps Up Cannabis Stocks: Tilray, Sundial, Aurora & GrowGen Among Top Cannabis Movers For July 20, 2021
July 20, 2021
GAINERS: Empower Clinics (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
General Cannabis, MariMed & Urban-Gro Among Top Cannabis Stock Movers On July 13, 2021
July 13, 2021
GAINERS: CURE Pharmaceutical Hldg (O...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cara Therapeutics Insights: Return On Capital Employed
June 22, 2021
During Q1, Cara Therapeutics (NASDAQ:CARA) brought in sales totaling $1.94 million. However, earnings decreased 130.09%, resulting in a loss of $23.56 million. Cara Therapeutics...
Via
Benzinga
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels
June 08, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Economy
Exposures
COVID-19
Cannabis
Economy
Cara Therapeutics: Return On Capital Employed Insights
June 03, 2021
During Q1, Cara Therapeutics (NASDAQ:CARA) brought in sales totaling $1.94 million. However, earnings decreased 130.09%, resulting in a loss of $23.56 million. Cara Therapeutics...
Via
Benzinga
Is Cara Therapeutics a Buy for Summer 2021?
May 29, 2021
The future of this troubled clinical-stage biotech rests on a single drug candidate that management hopes will treat an extremely common condition.
Via
The Motley Fool
Is Cara Therapeutics a Buy?
May 23, 2021
Maybe, if you're itching to speculate.
Via
The Motley Fool
Cannabis Stock Gainers And Losers From May 11, 2021
May 11, 2021
GAINERS: Claritas Pharmaceuticals (...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.